1. Jiang, Minlin, Jia, Keyi, Wang, Lei, He, Yayi, Zhou, Caicun. 2021. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy. In Acta pharmaceutica Sinica. B, 11, 2983-2994. doi:10.1016/j.apsb.2021.01.003. https://pubmed.ncbi.nlm.nih.gov/34729299/
2. Jiang, Qirui, Lin, Junyu, Wei, Qianqian, Hadano, Shinji, Shang, Huifang. 2022. Genetic and clinical characteristics of ALS patients with NEK1 gene variants. In Neurobiology of aging, 123, 191-199. doi:10.1016/j.neurobiolaging.2022.11.001. https://pubmed.ncbi.nlm.nih.gov/36443167/
3. He, Qiqing, Zhou, Yuting, Jin, Jianing, Hou, Binghui, Xie, Anmu. 2024. Association between NEK1 gene polymorphisms and the potential risk of sporadic Parkinson's disease in the Chinese Northern Han population: A case-control study. In Neuroscience letters, 837, 137913. doi:10.1016/j.neulet.2024.137913. https://pubmed.ncbi.nlm.nih.gov/39032803/
4. Hikoya, Akiko, Hosono, Katsuhiro, Ono, Kaoru, Ogata, Tsutomu, Hotta, Yoshihiro. 2022. A case of siblings with juvenile retinitis pigmentosa associated with NEK1 gene variants. In Ophthalmic genetics, 44, 480-485. doi:10.1080/13816810.2022.2141788. https://pubmed.ncbi.nlm.nih.gov/36341712/